A study shows that high levels of negatively charged lipids can lock growth receptors into an overactive state, driving ...
A hormone-related interleukin (IL)–epidermal growth factor receptor (EGFR) axis that underpins greater type 2 (T2) ...
New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.
Zacks Investment Research on MSN
BDTX: What silevertinib data say about EGFR NSCLC upside
Black Diamond Therapeutics, Inc. BDTX is building its equity story around a single, high-leverage asset: silevertinib, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results